Jair Soares
Psychiatry · San Antonio, TXNPI 1871501072
Payments from drug & device makers
Across 139 payments — averaging $1041.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$66K
- Sumitomo Pharma America, Inc.$44K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$9K
- Merck$8K
- Johnson & Johnson$5K
- AbbVie$5K
- plus $7K from 11 others
What the payments were for
- Consulting fees$54,24078%
- Speaking & faculty fees$8,40012%
- Travel & lodging$3,4975%
- Food & beverage$3,3015%
- Education$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 28 | $65,639 |
| Sumitomo Pharma America, Inc. | 7 | $44,110 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 8 | $8,517 |
| Merck | 10 | $8,251 |
| Johnson & Johnson | 9 | $5,431 |
| AbbVie(2 entities) | 14 | $5,288 |
| Livanova USA, Inc. | 9 | $3,462 |
| Boehringer Ingelheim | 2 | $1,395 |
| Sunovion Pharmaceuticals Inc. | 29 | $1,307 |
| Pfizer | 10 | $450 |
| Janssen Scientific Affairs, LLC | 4 | $358 |
| Supernus Pharmaceuticals, Inc. | 2 | $176 |
| Axsome Therapeutics, Inc. | 1 | $99 |
| E.r. Squibb & Sons, L.L.C. | 2 | $88 |
| Biogen | 2 | $67 |
| Neurocrine Biosciences, Inc. | 1 | $39 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$5,453
- LYBALVI$4,200
- VNS Therapy$3,004
- REJOYN$1,500
- VRAYLAR$354
- VNS Therapy Symmetry Model 8103 Generator$215
- QELBREE$122
- INVEGA SUSTENNA$121
- VNS - Symmetry$108
How this compares
$144,715 in reported general payments places this provider in the 95th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clonazepam | 24 | $350 |
| Sertraline Hcl | 12 | $109 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in San Antonio
- Thomas WeissSan Antonio$1.1M
- Jason MillerSan Antonio$869K
- Nathan JohnstonSan Antonio$435K
- Scott BartleyDallas$42.7M
- David BrownAustin$15.8M
- Rajinder ShiwachDesoto$15.4M
- Darin OkudaDallas$14.7M
- Jason MensahBeaumont$10.3M
- Michael DowningDallas$7.6M
- Rakesh JainLake Jackson$7.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.